Obesity-related Upregulation of Monocyte Chemotactic Factors in Adipocytes: Involvement of Nuclear Factor-kappaB and C-Jun NH2-terminal Kinase Pathways

Overview

Journal Diabetes

Specialty Endocrinology

Date 2008 Oct 7

PMID 18835938

Citations 80

Authors

Ping Jiao

Qiu Chen

Suketu Shah

Jing Du

Bo Tao

Iphigenia Tzameli

Weiqun Yan

Haiyan Xu

Affiliations

Soon will be listed here.

Abstract

Objective: We sought to evaluate the entire picture of all monocyte chemotactic factors that potentially contribute to adipose tissue macrophage accumulation in obesity.

Research Design And Methods: Expression and regulation of members in the entire chemokine superfamily were evaluated in adipose tissue and isolated adipocytes of obese versus lean mice. Kinetics of adipose tissue macrophage infiltration was characterized by fluorescence-activated cell sorting. The effects of fatty acids on stimulation of chemokine expression in adipocytes and underlying mechanisms were investigated.

Results: Six monocyte chemotactic factors were found to be predominantly upregulated in isolated adipocytes versus stromal vascular cells in obese mice for the first time, although most of them were previously reported to be upregulated in whole adipose tissue. In diet-induced obese mice, adipose tissue enlargement, increase of adipocyte number, and elevation of multiple chemokine expression precede the initiation of macrophage infiltration. Free fatty acids (FFAs) are found to be inducers for upregulating these chemokines in 3T3-L1 adipocytes, and this effect can be partially blunted by reducing Toll-like receptor 4 expression. FFAs induce expression of monocyte chemotactic factors in adipocytes via both transcription-dependent and -independent mechanisms. In contrast to the reported role of JNK as the exclusive mediator of FFA-induced monocyte chemoattractant protein-1 (MCP-1) expression in macrophages, we show a novel role of inhibitor of kappaB kinase-beta (IKKbeta) in mediating FFA-induced upregulation of all six chemokines and a role of JNK in FFA-induced upregulation of MCP-1 and MCP-3.

Conclusions: Multiple chemokines derived from adipocytes might contribute to obesity-related WAT macrophage infiltration with FFAs as potential triggers and involvement of both IKKbeta and JNK pathways.

Citing Articles

Regulation of the immune microenvironment by SUMO in diabetes mellitus.

Zhuo Y, Fu S, Qiu Y Front Immunol. 2025; 16:1506500.

PMID: 40078991 PMC: 11896877. DOI: 10.3389/fimmu.2025.1506500.

Anti-inflammatory effect of Angiotensin 1-7 in white adipose tissue.

Nishida N, Sugimoto S, Miyagaki S, Cho C, Konishi M, Goda T Adipocyte. 2025; 14(1):2449027.

PMID: 39803918 PMC: 11730366. DOI: 10.1080/21623945.2024.2449027.

Sarcopenia and cachexia: molecular mechanisms and therapeutic interventions.

Wang T, Zhou D, Hong Z MedComm (2020). 2025; 6(1):e70030.

PMID: 39764565 PMC: 11702502. DOI: 10.1002/mco2.70030.

The Role of Chemokines in Obesity and Exercise-Induced Weight Loss.

He W, Wang H, Yang G, Zhu L, Liu X Biomolecules. 2024; 14(9).

PMID: 39334887 PMC: 11430256. DOI: 10.3390/biom14091121.

Adiponectin Resistance in Obesity: Adiponectin Leptin/Insulin Interaction.

Engin A Adv Exp Med Biol. 2024; 1460:431-462.

PMID: 39287861 DOI: 10.1007/978-3-031-63657-8_15.

References

Mohanty P, Aljada A, Ghanim H, Hofmeyer D, Tripathy D, Syed T . Evidence for a potent antiinflammatory effect of rosiglitazone. J Clin Endocrinol Metab. 2004; 89(6):2728-35. DOI: 10.1210/jc.2003-032103. View

Audrey Nguyen M, Favelyukis S, Nguyen A, Reichart D, Scott P, Jenn A . A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via Toll-like receptors 2 and 4 and JNK-dependent pathways. J Biol Chem. 2007; 282(48):35279-92. DOI: 10.1074/jbc.M706762200. View

Ghanim H, Aljada A, Hofmeyer D, Syed T, Mohanty P, Dandona P . Circulating mononuclear cells in the obese are in a proinflammatory state. Circulation. 2004; 110(12):1564-71. DOI: 10.1161/01.CIR.0000142055.53122.FA. View

Pickup J, Mattock M, Chusney G, Burt D . NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia. 1997; 40(11):1286-92. DOI: 10.1007/s001250050822. View

Ricote M, Li A, Willson T, Kelly C, Glass C . The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature. 1998; 391(6662):79-82. DOI: 10.1038/34178. View

Jiang C, Ting A, Seed B . PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature. 1998; 391(6662):82-6. DOI: 10.1038/34184. View

Clement K, Viguerie N, Poitou C, Carette C, Pelloux V, Curat C . Weight loss regulates inflammation-related genes in white adipose tissue of obese subjects. FASEB J. 2004; 18(14):1657-69. DOI: 10.1096/fj.04-2204com. View

Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y . Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest. 2004; 114(12):1752-61. PMC: 535065. DOI: 10.1172/JCI21625. View

Cancello R, Henegar C, Viguerie N, Taleb S, Poitou C, Rouault C . Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes. 2005; 54(8):2277-86. DOI: 10.2337/diabetes.54.8.2277. View

10.

Di Gregorio G, Yao-Borengasser A, Rasouli N, Varma V, Lu T, Miles L . Expression of CD68 and macrophage chemoattractant protein-1 genes in human adipose and muscle tissues: association with cytokine expression, insulin resistance, and reduction by pioglitazone. Diabetes. 2005; 54(8):2305-13. DOI: 10.2337/diabetes.54.8.2305. View

11.

Audrey Nguyen M, Satoh H, Favelyukis S, Babendure J, Imamura T, Sbodio J . JNK and tumor necrosis factor-alpha mediate free fatty acid-induced insulin resistance in 3T3-L1 adipocytes. J Biol Chem. 2005; 280(42):35361-71. DOI: 10.1074/jbc.M504611200. View

12.

Chung S, Brown J, Provo J, Hopkins R, McIntosh M . Conjugated linoleic acid promotes human adipocyte insulin resistance through NFkappaB-dependent cytokine production. J Biol Chem. 2005; 280(46):38445-56. PMC: 1289266. DOI: 10.1074/jbc.M508159200. View

13.

Weisberg S, Hunter D, Huber R, Lemieux J, Slaymaker S, Vaddi K . CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J Clin Invest. 2005; 116(1):115-24. PMC: 1307559. DOI: 10.1172/JCI24335. View

14.

Kanda H, Tateya S, Tamori Y, Kotani K, Hiasa K, Kitazawa R . MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest. 2006; 116(6):1494-505. PMC: 1459069. DOI: 10.1172/JCI26498. View

15.

Shoelson S, Lee J, Goldfine A . Inflammation and insulin resistance. J Clin Invest. 2006; 116(7):1793-801. PMC: 1483173. DOI: 10.1172/JCI29069. View

16.

Kamei N, Tobe K, Suzuki R, Ohsugi M, Watanabe T, Kubota N . Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance. J Biol Chem. 2006; 281(36):26602-14. DOI: 10.1074/jbc.M601284200. View

17.

Ghanim H, Dhindsa S, Aljada A, Chaudhuri A, Viswanathan P, Dandona P . Low-dose rosiglitazone exerts an antiinflammatory effect with an increase in adiponectin independently of free fatty acid fall and insulin sensitization in obese type 2 diabetics. J Clin Endocrinol Metab. 2006; 91(9):3553-8. DOI: 10.1210/jc.2005-2609. View

18.

Shi H, Kokoeva M, Inouye K, Tzameli I, Yin H, Flier J . TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest. 2006; 116(11):3015-25. PMC: 1616196. DOI: 10.1172/JCI28898. View

19.

Tsukumo D, Carvalho-Filho M, Carvalheira J, Prada P, Hirabara S, Schenka A . Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance. Diabetes. 2007; 56(8):1986-98. DOI: 10.2337/db06-1595. View

20.

Aguirre V, Uchida T, Yenush L, Davis R, White M . The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307). J Biol Chem. 2000; 275(12):9047-54. DOI: 10.1074/jbc.275.12.9047. View